About Dr. Madala Ravikrishna, Medical Oncologist experience, education and Expertise. Book an online appointment for Dr. Madala Ravikrishna, Medical Oncologist, if available.

Dr. Madala Ravikrishna, Medical Oncologist

MBBS, MD (Radiation) , DM (Medical Oncology)

Medical Oncologist

• Medical Oncologist

• 
  

  Haemato Oncologist

,

• Biliary and Pancreatic Cancer
• Brain Tumors
• Breast Cancer
• Cancer Screening
• Cervical Cancers
• Colorectal Cancers
• Medical Oncology

,

• MBBS – Kurnool Medical College – 2013 – Kurnool
• MD – Radiotherapy – Sri Venkateswara Institute Of Medical Sciences – 2018 – Tirupati
• DM – Medical Oncology – Tata Memorial Hospital – 2022 – Maharashtra

,

• Internship Kurnool Medical College
• Senior Resident – Department of Radiation Oncology Venkata Padmavathi Institute of Medical Sciences – Tirupati
• Assistant Professor Tata Memorial Centre – Mumbai
• Consultant Medical Oncologist Kims Hospital – Begumpet – Currently Working

,

• 81137 Telangana State Medical Council 2013

,

• Patil V, Abraham G, Ravikrishna M, Bhattacharjee A, Noronha V, Parekh D, Menon N, Bajpai J, Prabhash K. Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in India.
• Bajpai J, Panda G, Ravikrishna M, Chandrasekharan A, Rekhi B, Bhargava P, Srinivas S, Laskar S, Mokal S, Khanna N, Patil V. Vascular endothelial growth factor as a potential prognosticator in Ewing Sarcoma: a tertiary care cancer centre experience from India.
• Madala RK, Krishnatry R, Noronha V, Patil V, Joshi A, Menon N, Muthuluri H, Prabhash K. Neurological deterioration in a patient with lung cancer and brain metastasis. Cancer
• Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A. Results of phase III randomised trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer, unsuitable for cisplatin-based chemoradiation. Journal of Clinical Oncology. 2023 Jan:JCO-22.
• Prathipati A, Jilla S, Subramanian BV, Madala RK. Impact of Various Prognostic Factors on Overall Survival, Disease-Free Survival and Patterns of Failure in Carcinoma Cervix: A Tertiary Care Centre Experience from South India. Indian Journal of Gynecologic Oncology. 2018 Mar;16:1-4.

Dr. Madala Ravikrishna, Medical Oncologist Contact number not available, Please check google for business profile